Clik here to view.
Prometheus Patents Struck Down, 9-0: Mayo Collaborative Services v....
In a strong rebuke to the Federal Circuit, a unanimous U.S. Supreme Court held (pdf), on March 20, 2012, that Prometheus Laboratories’ claims to methods of administering drugs to treat gastrointestinal...
View ArticleClik here to view.
Myriad Finally Reaches the Supreme Court (But Only For a Moment)
Yesterday, the Supreme Court (as we predicted last week that it might) GVR’d the certiorari petitions (pdf) of both parties in the Myriad Genetics case. Big news, right? Not really. What this means is...
View ArticleClik here to view.
Courts in Unsettled Territory turn to the Map Available: United States v....
We recently covered the Ninth Circuit’s split decision in Haskell v. Harris,1 which found DNA Fingerprinting of arrestees pursuant to California’s Prop 69 to be constitutionally sound. We also reported...
View ArticleClik here to view.
Applying Mayo to Myriad: Latest Decision Brings No New News (Plus: Why the...
The latest chapter in the Myriad gene patent litigation was written yesterday, with the Federal Circuit issuing its much anticipated opinion (pdf) after rehearing the case following the Supreme Court’s...
View ArticleClik here to view.
ENCODE, CODIS, and the Urgent Need to Focus on what is Scientifically and...
Sara Huston Katsanis, MS is an Associate in Research at the Institute for Genome Sciences & Policy at Duke University. On September 5, 2012, a coordinated release of 30 articles in Nature, Cell,...
View ArticleClik here to view.
Myriad Updates: Clinical Data as Trade Secrets and a Pending Certiorari Decision
Earlier this month, my colleagues John Conley, Robert Cook-Deegan, James Evans and I published a policy article in the European Journal of Human Genetics (EJHG) entitled “The next controversy in...
View ArticleClik here to view.
Supreme Court to Rule on Patentability of Human Genes
Robert Cook-Deegan contributed to this commentary. Dr. Cook-Deegan is a research professor in the Institute for Genome Sciences and Policy and the Sanford School of Public Policy at Duke University....
View ArticleClik here to view.
All Eyes on Maryland v. King: Recapping the Supreme Court Oral Argument
Seating was in short supply to hear oral arguments before the Supreme Court in what J. Alito referred to as “the most important criminal procedural case that this court has heard in decades,” Maryland...
View ArticleClik here to view.
Some Thoughts on Myriad After the Supreme Court Argument
On April 15, the Supreme Court heard oral arguments in Association for Molecular Pathology v. Myriad Genetics. This was another significant step—probably the penultimate one—in the long-running Myriad...
View ArticleClik here to view.
Myriad Back in Court Again — This Time as a Defendant
Myriad Genetics is once again embroiled in litigation over its BRCA-related patents. But this time Myriad is the defendant. Counsyl, Inc., a San Francisco-based company that focuses on genetic carrier...
View ArticleTroubles keep coming for 23andMe
As if the FDA warning letter wasn’t enough, 23andMe, Inc. now has a lawsuit on its hands. The suit, known as Casey v. 23andMe, was initiated on November 27, 2013, in federal court for the Southern...
View ArticleClik here to view.
District Court Denies Myriad’s Preliminary Injunction Against Ambry
In a 106-page opinion issued on March 10, 2014, Judge Robert Shelby of the federal district court in Salt Lake City denied Myriad Genetics’ Motion for Preliminary Injunction in its lawsuit against...
View ArticleClik here to view.
The Patent Dispute Over Gene Editing Technologies: The Broad Institute, Inc....
The patent dispute already called “the biggest in biotech history” is only getting started. On January 11, 2016, Administrative Law Judge (ALJ) Deborah Katz officially declared an interference over...
View ArticleGenetic information as “perceived disability”: Chadam v. PAUSD
Chadam v. PAUSD, as previously covered on Genomics Law Report, is a case in which parents of a school boy are alleging that a school district violated their son’s rights when it made the decision that...
View ArticleLitigating the Accountability of Clinical Genomics Laboratories
Seeking Accountability from Clinical Genomics Laboratories A wrongful death case pending in a federal court in Columbia, SC—Williams v. Quest Diagnostics, Inc., et al.—demonstrates the very high stakes...
View ArticleClik here to view.
ACLU v. Myriad Genetics, Round 2: The Problem of Governance-by-Guidance
Just about everyone interested enough in genomics and the law to read this post will know that the American Civil Liberties Union waged a long and ultimately successful legal campaign to invalidate...
View ArticleUpdate on Chadam v. Palo Alto Unified School District
About a year ago we reported on a case involving allegations of genetic discrimination by a school district in California. According to the allegations, in fall 2012 the Palo Alto Unified School...
View ArticleClik here to view.
Williams v. Athena Motion to Dismiss Hearing—SC Supreme Court May Be Asked to...
Foreword by John Conley Back on May 31, 2016, Contributing Editor Jennifer Wagner wrote a lengthy report on the newly filed case of Williams v. Quest Diagnostics, et al. As Jen recounted, plaintiff...
View ArticleKeeping an Eye on “Perceived Disability” Litigation in California: Chadam v....
We mentioned in January that the Ninth Circuit Court of Appeals reversed the District Court’s earlier decision to grant a motion to dismiss and is instead allowing the case of Chadam v. Palo Alto...
View ArticleA Constitutional Challenge to Alaska’s Genetic Privacy Statute
As part of its defense of a class action lawsuit that began in 2014, a genetic genealogy company (or DNA ancestry company as they are sometimes called) is challenging the constitutionality of the...
View Article
